Harrow Announces Investor & Analyst Day Details
Harrow, a prominent provider of ophthalmic disease management solutions in North America, has officially revealed the agenda for its highly anticipated Investor & Analyst Day. This event is scheduled for Friday, September 26, and will run from 11:30 a.m. to 3 p.m. ET. Attendees can join in-person in New York or access the live webcast.
Comprehensive Overview of Harrow
The Investor & Analyst Day promises a thorough overview of Harrow's business, featuring presentations from its leadership team. These sessions will shed light on Harrow's commercial portfolio, development pipeline, and long-term vision for the company. Notably, esteemed physician key opinion leaders will present insights on the evolving treatment paradigms and market dynamics affecting patient care.
Key Speakers to Feature
The lineup of featured speakers includes:
- Paul Karpecki, OD: A respected optometrist specializing in cornea and external disease. His extensive experience in dry eye disease will provide valuable insight.
- Raj Patel, MD, MS: A retinal specialist with expertise in macular degeneration and diabetic retinopathy, whose research and innovative treatment approaches are highly regarded.
- Seenu Hariprasad, MD: An internationally recognized vitreoretinal surgeon known for developing impactful surgical techniques and conducting significant clinical research.
- Maggie Jeffries, MD, FASA: Specializing in ophthalmic anesthesia and renowned for her contributions to outpatient surgical techniques.
Investor Day Agenda
The preliminary agenda of the Investor & Analyst Day includes a number of enlightening topics:
- Welcome & Opening Remarks by Mike Biega, VP of IR and Communications.
- Harrow Overview & Vision by Mark L. Baum, Chief Executive Officer.
- Financial Update presented by Andrew Boll, President & Chief Financial Officer.
- Harrow's Pipeline Products overview by Amir Shojaei, Chief Scientific Officer.
- MELT-300 Development Overview and Potential by Larry Dillaha, MD, CEO of Melt Pharmaceuticals.
- An Expert's Perspective on Procedural Sedation by Maggie Jeffries, MD.
- Commercial Vision by Patrick Sullivan, Head of Commercial.
- VEVYE Overview led by Maria Lloyd, VP of Dry Eye.
- Patient Access & Affordability of Specialty Products by Prashanth Annavajjhala, Chief of Staff to CEO.
- Retina Products Overview presented by Aly Harrison, VP of Retina Portfolio.
Register to Attend
In-person attendance is specifically open to invited research analysts and institutional investors only. For those interested in attending in-person, please reach out to Mike Biega via email. The live video webcast is open to all others wishing to join the event virtually.
Webcast Information
The live webcast will be accessible on the Harrow website, while a replay will also be available shortly after the event concludes. A copy of the slide presentation will be shared on this webpage at the event's start.
About Harrow
Harrow, Inc. (NASDAQ: HROW) is a leading provider of ophthalmic disease management solutions throughout North America. The company focuses on delivering a comprehensive range of products aimed at treating conditions affecting both the front and back of the eye, which include prevalent issues like dry eye disease, wet age-related macular degeneration, and cataracts. Harrow's core mission is to ensure medications are safe, effective, and affordable, ultimately enhancing patient compliance and outcomes.
Frequently Asked Questions
What is the purpose of Harrow's Investor & Analyst Day?
The event aims to provide an in-depth overview of Harrow's business strategies, product pipeline, and future vision to investors and analysts.
Who are the main speakers at the event?
Notable speakers include Dr. Paul Karpecki, Dr. Raj Patel, Dr. Seenu Hariprasad, and Dr. Maggie Jeffries, among others.
How can I register for the event?
Investors and analysts may register to attend in person by contacting Mike Biega directly via email. The webcast will be accessible to the general public.
What topics will be covered during the presentations?
The agenda includes topics about Harrow's vision, financial updates, and insights from leading experts in ophthalmology regarding current treatment paradigms.
Where can I access the live webcast?
The live webcast will be available on Harrow's official website, along with a replay after the event.
